Ivan Vrkic is a co-founder of CellType, a drug discovery company. He studied machine learning at Yale and EPFL, contributed to Cell2Sentence research published at ICML, and previously led foundation model training at a biotech startup and developed software for CERN's Large Hadron Collider.
Intro paths
YC
Ivan went through Y Combinator (Winter 2026) — any YC alum in your network can reach them through the YC community.
→
In turn, Ivan can intro founders to CellType's investors below.
CellType's investors · 1
Co-founders
David van Dijk· Co-Founder & CEO